By Counterforce Health Team in iLink® (corneal cross-linking system) —

How to Get iLink® Corneal Cross-Linking Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting iLink® Covered by Aetna CVS Health in New Jersey

Aetna CVS Health covers FDA-approved iLink® corneal cross-linking for progressive keratoconus with prior authorization. You need documented disease progression via serial corneal topography (3-6 months apart showing ≥1.0 D increase in Kmax), adequate corneal thickness (≥400 microns), and comprehensive clinical documentation. Submit through your cornea specialist via Aetna's provider portal with topography reports, pachymetry results, and medical necessity letter. Standard review takes 14-30 days; expedited decisions within 72 hours for urgent cases. If denied, appeal within 180 days using New Jersey's IHCAP external review program.

First step today: Contact your cornea specialist to verify Aetna network participation and begin gathering serial topography showing progression.

Table of Contents

  1. Coverage Requirements at a Glance
  2. Step-by-Step: Fastest Path to Approval
  3. Common Denial Reasons & How to Fix Them
  4. Appeals Process: New Jersey IHCAP
  5. Clinician Corner: Medical Necessity Documentation
  6. Costs and Patient Assistance
  7. When to Escalate
  8. Frequently Asked Questions

Coverage Requirements at a Glance

Requirement What It Means Documentation Needed Source
Prior Authorization Required before procedure Cornea specialist submission via provider portal Aetna Precertification Lists
Progressive Disease ≥1.0 D increase in Kmax over 3-6 months Serial corneal topography reports Coverage Policy
Corneal Thickness ≥400 microns confirmed Pachymetry measurements Clinical Bulletin
Age Requirement ≥14 years Clinical documentation FDA Approval Guidelines
ICD-10 Codes H18.601-H18.609 (keratoconus) Diagnosis in medical records ASCRS Guidelines
FDA-Approved System iLink® with Photrexa only Procedure notes specifying system Glaukos FDA Information

Step-by-Step: Fastest Path to Approval

1. Verify Network Participation (Patient)

Contact your cornea specialist's office to confirm they're in-network with Aetna CVS Health and perform iLink® procedures. Out-of-network providers require additional authorization steps.

2. Gather Baseline Documentation (Clinic Staff)

Collect serial corneal topography performed 3-6 months apart showing measurable Kmax progression. Essential documents include:

  • Two or more topography reports with specific Kmax values and dates
  • Pachymetry confirming ≥400 micron thickness
  • Complete ophthalmologic examination notes
  • Visual acuity measurements over time

3. Submit Prior Authorization (Cornea Specialist)

Timeline: 14-30 days for standard review; 72 hours for expedited Method: Aetna provider portal at www.availity.com or specialty phone line 1-866-814-5506

Required submission packet:

  • Prior authorization form with CPT code 0402T
  • Medical necessity letter addressing vision preservation
  • Serial topography demonstrating progression
  • Pachymetry results
  • ICD-10 codes H18.601-H18.609

4. Track Authorization Status (Patient/Clinic)

Monitor submission through the provider portal. Aetna typically responds within the stated timeframe unless additional information is requested.

5. Schedule Procedure Upon Approval (Patient)

Once authorized, schedule your iLink® procedure promptly. Authorizations typically have validity periods of 30-90 days.

6. Appeal if Denied (Patient/Clinic)

If denied, you have 180 days to file an internal appeal, followed by external review through New Jersey's IHCAP program if needed.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
Insufficient progression evidence Submit additional topography with clear Kmax increases 2-3 topography reports showing ≥1.0 D steepening over 3-6 months
"Experimental/investigational" Emphasize FDA approval since 2016 FDA approval documentation and clinical trial data
Not medically necessary Detailed necessity letter focusing on vision preservation Comprehensive letter addressing keratoconus progression risks
Alternative treatments available Document contact lens failure or contraindications Trial records showing intolerance or inadequate correction
Insufficient corneal thickness Provide updated pachymetry with clinical justification Recent measurements confirming ≥400 microns at thinnest point
Non-participating provider Switch to in-network specialist or request exception Network verification or medical exception request
From our advocates: We've seen denials overturned when providers include specific Kmax progression values (e.g., "increased from 48.2 D to 50.1 D over 4 months") rather than general statements about "worsening keratoconus." Precise measurements strengthen the medical necessity case significantly.

Appeals Process: New Jersey IHCAP

Internal Appeal with Aetna CVS Health

Timeline: File within 180 days of denial; 30-day decision Method: Submit through member portal or mail to address on denial letter

Include in your appeal:

  • Original denial letter
  • Additional medical evidence addressing denial reason
  • Updated medical necessity letter
  • Peer-reviewed studies supporting treatment

External Review: New Jersey IHCAP

If your internal appeal is denied, New Jersey offers free external review through the Independent Health Care Appeals Program (IHCAP).

Eligibility: Complete Aetna's internal appeal process first Timeline: File within 60 days of final internal denial Cost: Free to patients Administrator: Maximus Federal Services

How to file:

  1. Contact IHCAP at 1-888-393-1062
  2. Submit appeal with all medical records
  3. Include physician letter explaining medical necessity
  4. Maximus assigns ophthalmology specialist reviewer

Review timeline:

  • Standard cases: 45 days maximum
  • Urgent cases: 48 hours for time-sensitive situations
  • Preliminary review: 5 business days to confirm eligibility

Success factors: IHCAP reviewers consider FDA approval, clinical guidelines, and medical necessity. Include comprehensive documentation and emphasize vision preservation goals.

Clinician Corner: Medical Necessity Documentation

Medical Necessity Letter Checklist

Your cornea specialist's letter should address these key points:

Patient History:

  • Diagnosis confirmation with ICD-10 codes H18.601-H18.609
  • Symptom progression affecting daily activities
  • Previous treatments attempted and outcomes

Clinical Evidence:

  • Serial topography showing specific Kmax progression values
  • Pachymetry confirming adequate corneal thickness
  • Visual acuity measurements demonstrating functional impact

Treatment Rationale:

  • FDA approval of iLink® system for progressive keratoconus
  • Risk of continued progression without intervention
  • Expected outcomes based on clinical literature

Guidelines and Citations: Reference these authoritative sources:

Peer-to-Peer Review Preparation

If Aetna requests a peer-to-peer review, prepare to discuss:

  • Specific progression measurements from serial topography
  • Why alternative treatments are insufficient
  • FDA approval and safety profile of iLink® system
  • Patient's functional vision goals and quality of life impact

Costs and Patient Assistance

Typical Costs

  • With insurance approval: Patient responsibility varies by plan (copay, coinsurance, or deductible)
  • Self-pay: $2,500-$4,000 per eye at most facilities
  • Coverage rate: Over 95% approval for documented progressive cases with FDA-approved iLink® system

Financial Assistance Options

Glaukos Patient Support: Contact Glaukos directly for information about patient assistance programs and copay support options.

CareCredit Healthcare Financing: Many ophthalmology practices accept CareCredit for extended payment plans with promotional financing options.

State Programs: New Jersey residents may qualify for additional assistance through state healthcare programs. Contact the New Jersey Department of Banking and Insurance consumer hotline at 1-800-446-7467.

When to Escalate

Contact the New Jersey Department of Banking and Insurance if you experience:

  • Unreasonable delays in prior authorization review
  • Repeated denials despite meeting coverage criteria
  • Provider network access issues

Contact Information:

  • Consumer Hotline: 1-800-446-7467
  • IHCAP-specific assistance: 1-888-393-1062
  • Online complaint filing: DOBI website

For urgent vision-threatening situations, request expedited review and consider contacting your state representative's office for additional advocacy support.

Frequently Asked Questions

How long does Aetna CVS Health prior authorization take in New Jersey? Standard review takes 14-30 days. Expedited review for urgent cases provides decisions within 72 hours when clinical urgency is documented.

What if iLink® is considered non-formulary by my plan? Submit a formulary exception request with your prior authorization. Include FDA approval documentation and medical necessity justification.

Can I request an expedited appeal if my vision is worsening rapidly? Yes. Document rapid progression and functional vision decline. Both Aetna internal appeals and New Jersey IHCAP offer expedited review for urgent cases.

Does step therapy apply to corneal cross-linking? Typically no, since iLink® is the only FDA-approved cross-linking system. However, you may need to document failure of conservative management like specialty contact lenses.

What happens if my cornea specialist is out-of-network? Request a network exception if no in-network specialists perform iLink® in your area. Include documentation of provider expertise and geographic necessity.

Can I appeal a denial even if I already had the procedure? Yes, you can appeal for reimbursement of services already provided. New Jersey allows appeals for both prospective authorization and retroactive coverage determinations.

How successful are appeals for corneal cross-linking in New Jersey? While specific statistics aren't published, specialty ophthalmology procedures with FDA approval and documented medical necessity have favorable appeal outcomes, particularly through IHCAP's physician review process.

What if I move from another state with different coverage? New Jersey plans must honor continuous coverage provisions. Provide documentation of your previous coverage and any ongoing treatment plans.

About Counterforce Health

Counterforce Health specializes in turning insurance denials into successful appeals for complex medical treatments like corneal cross-linking. Our platform analyzes denial letters, identifies specific coverage criteria, and generates evidence-backed appeals that address payers' exact requirements. For patients and providers navigating prior authorization challenges, we provide the targeted documentation and procedural expertise that significantly improves approval rates.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies and appeal procedures may vary by specific plan and change over time. Always consult with your healthcare provider and insurance plan for the most current requirements and procedures specific to your situation.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.